HC Surgical Specialists is acquiring a majority stake in a clinic for around $1.23 million, so as to broaden the range of medical services that can be offered.
The clinic, LS Lee Surgery, is run by one Dr Lee Lip Seng, a specialist in gallstones, gallbladder, & bile duct surgery.
HCSS, under CEO Dr Heah Sieu Min, focuses on endoscopic procedures.
For the most recent financial year ended June 30 2025, Chirurgia, an entity used by Dr Lee to own LS Lee Surgery, recorded a net profit before tax of some $495,000.
As at June 30, the net tangible asset value and the net asset value of Chirurgia were both $1,241,000.
Following the initial 51% stake, Dr Lee will sell the remaining 49% to HCSS by Nov 30 2029. In the meantime, he will manage Chirurgia for an initial period of ten years starting from April 7.
See also: CK Hutchison starts London arbitration against Maersk over Panama
HCSS shares last traded at 37 cents, up 2.78% year to date.
